Artificial Cornea and Corneal Implant Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Description
Artificial Cornea and Corneal Implant Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global artificial cornea and corneal implant market size reached US$ 412.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 612.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Artificial cornea and corneal implant refer to the surgical procedure conducted to replace parts of the damaged cornea with healthy corneal tissue obtained from a donor. The procedures are usually performed for the treatment of keratoconus, infectious keratitis, corneal ulcers and Fuchs dystrophy diseases. They include various medical procedures, such as penetrating and endothelial keratoplasty, that involve the transplantation of entire corneal stem cells. The implants are commonly available in synthetic and biosynthetic variants, which are manufactured using recombinant collagen and chemical substances. The implant procedures aid in restoring vision, relieving pain and treating damaged corneas. As a result, these procedures are widely conducted in hospitals and ophthalmic and ambulatory surgical centers (ASCs).
Artificial Cornea and Corneal Implant Market Trends:
The increasing prevalence of corneal infections and eye-related disorders among the masses is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Artificial cornea and corneal implant procedures are extensively used for the timely treatment of these disorders and the prevention of corneal blindness. Additionally, the increasing preference for penetrating keratoplasty procedures is favoring the market growth. These surgical procedures involve full-thickness corneal transplantation, which aids in treating ecstatic corneal diseases, such as keratoconus and pellucid marginal degeneration. Various product innovations, such as the development of three-dimensional (3D) printed artificial corneas with enhanced biocompatibility and customizability, are contributing to the market growth. In line with this, the increasing demand for artificial cornea and corneal implants to treat cloudy cornea caused by prolonged exposure to screen times is positively impacting the market growth. Other factors, including significant improvements in the healthcare infrastructure, along with the implementation of various government initiatives to prevent visual impairment among the masses, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial cornea and corneal implant market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, transplant type, disease indication and end user.
Breakup by Type:
Human Cornea
Artificial Cornea
Breakup by Transplant Type:
Penetrating Keratoplasty
Endothelial Keratoplasty
Anterior Lamellar Keratoplasty
Keratoprosthesis
Breakup by Disease Indication:
Fuchs' Dystrophy
Fungal Keratitis
Keratoconus
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC and San Diego Eye Bank.
Key Questions Answered in This Report
1. What was the size of the global artificial cornea and corneal implant market in 2022?
2. What is the expected growth rate of the global artificial cornea and corneal implant market during 2023-2028?
3. What are the key factors driving the global artificial cornea and corneal implant market?
4. What has been the impact of COVID-19 on the global artificial cornea and corneal implant market?
5. What is the breakup of the global artificial cornea and corneal implant market based on the type?
6. What is the breakup of the global artificial cornea and corneal implant market based on the transplant type?
7. What is the breakup of the global artificial cornea and corneal implant market based on the disease indication?
8. What is the breakup of the global artificial cornea and corneal implant market based on the end user?
9. What are the key regions in the global artificial cornea and corneal implant market?
10. Who are the key players/companies in the global artificial cornea and corneal implant market?
The global artificial cornea and corneal implant market size reached US$ 412.5 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 612.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.5% during 2023-2028.
Artificial cornea and corneal implant refer to the surgical procedure conducted to replace parts of the damaged cornea with healthy corneal tissue obtained from a donor. The procedures are usually performed for the treatment of keratoconus, infectious keratitis, corneal ulcers and Fuchs dystrophy diseases. They include various medical procedures, such as penetrating and endothelial keratoplasty, that involve the transplantation of entire corneal stem cells. The implants are commonly available in synthetic and biosynthetic variants, which are manufactured using recombinant collagen and chemical substances. The implant procedures aid in restoring vision, relieving pain and treating damaged corneas. As a result, these procedures are widely conducted in hospitals and ophthalmic and ambulatory surgical centers (ASCs).
Artificial Cornea and Corneal Implant Market Trends:
The increasing prevalence of corneal infections and eye-related disorders among the masses is one of the key factors driving the growth of the market. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Artificial cornea and corneal implant procedures are extensively used for the timely treatment of these disorders and the prevention of corneal blindness. Additionally, the increasing preference for penetrating keratoplasty procedures is favoring the market growth. These surgical procedures involve full-thickness corneal transplantation, which aids in treating ecstatic corneal diseases, such as keratoconus and pellucid marginal degeneration. Various product innovations, such as the development of three-dimensional (3D) printed artificial corneas with enhanced biocompatibility and customizability, are contributing to the market growth. In line with this, the increasing demand for artificial cornea and corneal implants to treat cloudy cornea caused by prolonged exposure to screen times is positively impacting the market growth. Other factors, including significant improvements in the healthcare infrastructure, along with the implementation of various government initiatives to prevent visual impairment among the masses, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial cornea and corneal implant market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, transplant type, disease indication and end user.
Breakup by Type:
Human Cornea
Artificial Cornea
Breakup by Transplant Type:
Penetrating Keratoplasty
Endothelial Keratoplasty
Anterior Lamellar Keratoplasty
Keratoprosthesis
Breakup by Disease Indication:
Fuchs' Dystrophy
Fungal Keratitis
Keratoconus
Others
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advancing Sight Network, AJL Ophthalmic S.A., Aurolab, Corneat Vision Ltd, EyeYon Medical, Florida Lions Eye Bank, Keramed Inc., L V Prasad Eye Institute, LinkoCare Life Sciences AB, Mediphacos, Presbia PLC and San Diego Eye Bank.
Key Questions Answered in This Report
1. What was the size of the global artificial cornea and corneal implant market in 2022?
2. What is the expected growth rate of the global artificial cornea and corneal implant market during 2023-2028?
3. What are the key factors driving the global artificial cornea and corneal implant market?
4. What has been the impact of COVID-19 on the global artificial cornea and corneal implant market?
5. What is the breakup of the global artificial cornea and corneal implant market based on the type?
6. What is the breakup of the global artificial cornea and corneal implant market based on the transplant type?
7. What is the breakup of the global artificial cornea and corneal implant market based on the disease indication?
8. What is the breakup of the global artificial cornea and corneal implant market based on the end user?
9. What are the key regions in the global artificial cornea and corneal implant market?
10. Who are the key players/companies in the global artificial cornea and corneal implant market?
Table of Contents
145 Pages
- 1 Preface
- 2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
- 3 Executive Summary
- 4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
- 5 Global Artificial Cornea and Corneal Implant Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
- 6 Market Breakup by Type
- 6.1 Human Cornea
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Artificial Cornea
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 7 Market Breakup by Transplant Type
- 7.1 Penetrating Keratoplasty
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Endothelial Keratoplasty
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Anterior Lamellar Keratoplasty
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Keratoprosthesis
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 8 Market Breakup by Disease Indication
- 8.1 Fuchs' Dystrophy
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Fungal Keratitis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Keratoconus
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Others
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Ambulatory Surgical Centers
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Specialty Clinics
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
- 11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
- 12 Value Chain Analysis
- 13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
- 14 Price Analysis
- 15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Advancing Sight Network
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.2 AJL Ophthalmic S.A.
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Aurolab
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Corneat Vision Ltd
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 EyeYon Medical
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 Florida Lions Eye Bank
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Keramed Inc.
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 L V Prasad Eye Institute
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 LinkoCare Life Sciences AB
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Mediphacos
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Presbia PLC
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.12 San Diego Eye Bank
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
